Pharmaceutical Technology on MSN9 小时
FDA approves AstraZeneca FluMist ‘flu vaccine for self-administration
The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...
FDA approves FluMist for self-administration
The FluMist vaccine can now be self-administered after the FDA approved its use to treat the influenza disease.
Nasal spray flu vaccine gets FDA approval for home use: ‘A good alternative’
The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...
Worcester Telegram on MSN3 小时
FDA approves at-home flu vaccine nasal spray. Here's what to know about it.
AstraZeneca has a new at-home flu vaccine coming out. When will it arrive and how will it be administered? Here's what to ...
金融界财经 on MSN20 小时
喷一喷预防流感 FDA批准阿斯利康FluMist疫苗
美国FDA批准了阿斯利康旗下的无针鼻腔喷雾剂FluMist，用于预防2至49岁人群中由A型和B型流感病毒引起的流感疾病。FluMist成为首款可供符合条件的患者自行接种或由照护者接种的流感疫苗。
FDA approves ‘FluMist,' says no healthcare provider needed
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
WebMD20 小时
FDA Approves First At-Home Nasal Flu Vaccine
Sept. 23, 2024 – The FDA on Friday approved FluMist, a nasal spray flu vaccine that you or a caregiver can now give at home – no health care provider needed. It’s the first flu vaccine of its kind, ...
FDA批准FluMist可在家自行使用
英国剑桥 - ...
The American Journal of Managed Care2 小时
FDA Approves First Self-Administered Nasal Spray Flu Vaccine
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...
FDA approves FluMist for upcoming flu season
The Food and Drug Administration announced on Friday an approval of a new self- and caregiver-administered nose spray against ...
healthcarepackaging8 小时
FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver-Administration
· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist ...
阿斯利康制药的FluMist现获美国批准可在家使用
阿斯利康制药(LSE/STO/Nasdaq: AZN)已获得美国食品和药物管理局(FDA)批准,其流感疫苗FluMist可以自行使用,这标志着个人接种流感疫苗方式的重大转变。 今天发布的公告强调,FluMist是唯一获准可由49岁及以下成年人以及2-17岁个人在家自行或由看护人施用的流感疫苗。 FDA的决定基于一份全面的申请,其中包括一项可用性研究,显示18岁以上的个人可以自行使用FluMist或 ...